These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

891 related items for PubMed ID: 16968409

  • 1. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
    Grcević D, Lukić IK, Kovacić N, Ivcević S, Katavić V, Marusić A.
    Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
    [Abstract] [Full Text] [Related]

  • 2. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 3. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K, Kudo A.
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [Abstract] [Full Text] [Related]

  • 4. Gene array identification of osteoclast genes: differential inhibition of osteoclastogenesis by cyclosporin A and granulocyte macrophage colony stimulating factor.
    Day CJ, Kim MS, Stephens SR, Simcock WE, Aitken CJ, Nicholson GC, Morrison NA.
    J Cell Biochem; 2004 Feb 01; 91(2):303-15. PubMed ID: 14743390
    [Abstract] [Full Text] [Related]

  • 5. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov 01; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 6. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH.
    Mol Pharmacol; 2010 Jan 01; 77(1):17-25. PubMed ID: 19828731
    [Abstract] [Full Text] [Related]

  • 7. Bifurcation of osteoclasts and dendritic cells from common progenitors.
    Miyamoto T, Ohneda O, Arai F, Iwamoto K, Okada S, Takagi K, Anderson DM, Suda T.
    Blood; 2001 Oct 15; 98(8):2544-54. PubMed ID: 11588053
    [Abstract] [Full Text] [Related]

  • 8. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
    Mirosavljevic D, Quinn JM, Elliott J, Horwood NJ, Martin TJ, Gillespie MT.
    J Bone Miner Res; 2003 Jun 15; 18(6):984-93. PubMed ID: 12817750
    [Abstract] [Full Text] [Related]

  • 9. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
    Urushibara M, Takayanagi H, Koga T, Kim S, Isobe M, Morishita Y, Nakagawa T, Löeffler M, Kodama T, Kurosawa H, Taniguchi T.
    Arthritis Rheum; 2004 Mar 15; 50(3):794-804. PubMed ID: 15022321
    [Abstract] [Full Text] [Related]

  • 10. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms.
    Weitzmann MN, Cenci S, Rifas L, Haug J, Dipersio J, Pacifici R.
    J Bone Miner Res; 2001 Feb 15; 16(2):328-37. PubMed ID: 11204433
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ).
    Odkhuu E, Koide N, Haque A, Tsolmongyn B, Naiki Y, Hashimoto S, Komatsu T, Yoshida T, Yokochi T.
    Immunol Lett; 2012 Feb 29; 142(1-2):34-40. PubMed ID: 22193059
    [Abstract] [Full Text] [Related]

  • 12. CD137L- and RANKL-mediated reverse signals inhibit osteoclastogenesis and T lymphocyte proliferation.
    Senthilkumar R, Lee HW.
    Immunobiology; 2009 Feb 29; 214(2):153-61. PubMed ID: 19167994
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
    Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M.
    Biochem Biophys Res Commun; 2005 Apr 15; 329(3):839-45. PubMed ID: 15752732
    [Abstract] [Full Text] [Related]

  • 14. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta.
    Lari R, Fleetwood AJ, Kitchener PD, Cook AD, Pavasovic D, Hertzog PJ, Hamilton JA.
    Bone; 2007 Feb 15; 40(2):323-36. PubMed ID: 17055352
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H, Asagiri M, Kubota T, Oka K, Osada T, Sugiyama C, Saito H, Aoki K, Ohya K, Takayanagi H, Umezawa K.
    J Bone Miner Res; 2005 Apr 15; 20(4):653-62. PubMed ID: 15765185
    [Abstract] [Full Text] [Related]

  • 16. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
    Gorny G, Shaw A, Oursler MJ.
    Exp Cell Res; 2004 Mar 10; 294(1):149-58. PubMed ID: 14980510
    [Abstract] [Full Text] [Related]

  • 17. TNFα inhibits the development of osteoclasts through osteoblast-derived GM-CSF.
    Atanga E, Dolder S, Dauwalder T, Wetterwald A, Hofstetter W.
    Bone; 2011 Nov 10; 49(5):1090-100. PubMed ID: 21884837
    [Abstract] [Full Text] [Related]

  • 18. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K, Tanabe N, Suzuki N, Kawato T, Takeichi O, Tsuzukibashi O, Makimura M, Ito K, Maeno M.
    Life Sci; 2007 Mar 13; 80(14):1311-8. PubMed ID: 17306833
    [Abstract] [Full Text] [Related]

  • 19. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes.
    Shinoda K, Sugiyama E, Taki H, Harada S, Mino T, Maruyama M, Kobayashi M.
    Bone; 2003 Oct 13; 33(4):711-20. PubMed ID: 14555277
    [Abstract] [Full Text] [Related]

  • 20. Tetracyclines convert the osteoclastic-differentiation pathway of progenitor cells to produce dendritic cell-like cells.
    Kinugawa S, Koide M, Kobayashi Y, Mizoguchi T, Ninomiya T, Muto A, Kawahara I, Nakamura M, Yasuda H, Takahashi N, Udagawa N.
    J Immunol; 2012 Feb 15; 188(4):1772-81. PubMed ID: 22250082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.